{
  "ptid_time": "098_S_0896_2016-01-07",
  "img_path": "/data/qiuhui/data/adni/images/098_S_0896/2016-01-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 73,914 mm³, 57.2% above the reference mean. With a Z-score of 1.66 (95.2th percentile), this represents moderate enlargement; hippocampal volume measures 4,917 mm³, 29.4% below the reference mean. With a Z-score of -2.54 (0.5th percentile), this represents significant atrophy; whole brain volume measures 1,099,250 mm³, 6.8% above the reference mean. With a Z-score of 0.89 (81.4th percentile), this represents normal volume ; entorhinal cortex volume measures 2,519 mm³, 36.5% below the reference mean. With a Z-score of -2.39 (0.8th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,889 mm³, 1.0% below the reference mean. With a Z-score of -0.08 (46.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,340 mm³, 5.8% above the reference mean. With a Z-score of 0.52 (69.8th percentile), this represents normal volume . ",
  "text_data": "Age is 85.8 years. Gender is Male. Education: 16 years. MMSE: 30.0. MoCA: 22.0. Logical Memory: 3.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.13 SUVR (normal ); Amyloid beta: 879.10 pg/mL (normal ); Total tau: 282.00 pg/mL (normal ); Phosphorylated tau: 24.22 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and entorhinal cortex atrophy, which are hallmark features of Alzheimer's disease, despite normal CSF biomarkers (Aβ, T-tau, P-tau) and AV45 (amyloid PET). The MoCA score of 22 suggests mild cognitive impairment, while the MMSE of 30 is unexpectedly normal, possibly due to test insensitivity. The absence of APOE4 and normal amyloid markers may indicate non-amyloid pathology (e.g., primary age-related tauopathy or hippocampal sclerosis).  \n\n**Diagnosis:** **MCI** (likely amnestic subtype, with imaging evidence of AD-like neurodegeneration but biomarker discordance).  \n\n**Confidence:** **Medium** (due to conflicting biomarkers and cognitive scores; hippocampal atrophy strongly suggests progression toward dementia, but normal amyloid/tau complicates a definitive AD diagnosis).",
  "timestamp": "2025-07-26T10:42:55.061766"
}